Alexandre Karras

Corrigendum to "Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis" [European Journal of Internal Medicine 147 (2026) 106742].

Journal: European journal of internal medicine

Published: July 15, 2026

Drug interaction between maribavir and rifampin: a case report.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 28, 2026

Thrombotic Microangiopathy, Cryoglobulinemia, and Acute Kidney Injury in Patients With Monoclonal Gammopathy: A Case Series.

Journal: American journal of hematology

Published: January 20, 2026

Outcomes and Validation of Histopathological Scores in Pediatric ANCA-vasculitis.

Journal: Kidney international reports

Published: December 23, 2025

Towards more targeted therapies in the treatment of ANCA-associated vasculitides

Journal: La Revue du praticien

Published: October 23, 2025

Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counselling.

Journal: RMD open

Published: October 12, 2025

Outcomes and Predictors of Treatment Response in Patients With Pure Lupus Membranous Nephropathy.

Journal: Kidney international reports

Published: October 08, 2025

Spectrum of Anti-Factor B-Associated Glomerular Diseases in Adults.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: October 08, 2025

Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis.

Journal: European journal of internal medicine

Published: September 26, 2025

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Journal: Kidney international

Published: September 19, 2025

Corrigendum to "Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis" [European Journal of Internal Medicine 147 (2026) 106742].

Corrigendum to "Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis" [European Journal of Internal Medicine 147 (2026) 106742].

Drug interaction between maribavir and rifampin: a case report.

Drug interaction between maribavir and rifampin: a case report.

Thrombotic Microangiopathy, Cryoglobulinemia, and Acute Kidney Injury in Patients With Monoclonal Gammopathy: A Case Series.

Thrombotic Microangiopathy, Cryoglobulinemia, and Acute Kidney Injury in Patients With Monoclonal Gammopathy: A Case Series.

Outcomes and Validation of Histopathological Scores in Pediatric ANCA-vasculitis.

Outcomes and Validation of Histopathological Scores in Pediatric ANCA-vasculitis.

Towards more targeted therapies in the treatment of ANCA-associated vasculitides

Towards more targeted therapies in the treatment of ANCA-associated vasculitides

Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counselling.

Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counselling.

Outcomes and Predictors of Treatment Response in Patients With Pure Lupus Membranous Nephropathy.

Outcomes and Predictors of Treatment Response in Patients With Pure Lupus Membranous Nephropathy.

Spectrum of Anti-Factor B-Associated Glomerular Diseases in Adults.

Spectrum of Anti-Factor B-Associated Glomerular Diseases in Adults.

Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis.

Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis.

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Effect of Steroids on Anti-nephrin Autoantibodies and B cells in Minimal Change Disease.

Effect of Steroids on Anti-nephrin Autoantibodies and B cells in Minimal Change Disease.

Authors' Reply: Chronic Lesions in Scleroderma Renal Crisis: A Protective Clue?

Authors' Reply: Chronic Lesions in Scleroderma Renal Crisis: A Protective Clue?